6:43 PM
 | 
Apr 02, 2007
 |  BC Extra  |  Financial News

Bioenvision raises $30 million

BIVN raised $30 million through the sale of 8 million shares at $3.75 in a registered direct offering. JPMorgan was the placement agent. The shares...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >